Cargando…
Repeat Gamma Knife surgery for vestibular schwannomas
BACKGROUND: Gamma Knife (GK) surgery is a recognized treatment option for the management of small to medium-sized vestibular schwannoma (VS) associated with high-tumor control and low morbidity. When a radiosurgical treatment fails to stop tumor growth, repeat GK surgery can be proposed in selected...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596053/ https://www.ncbi.nlm.nih.gov/pubmed/26500799 http://dx.doi.org/10.4103/2152-7806.166173 |
_version_ | 1782393714280235008 |
---|---|
author | Lonneville, Sarah Delbrouck, Carine Renier, Cécile Devriendt, Daniel Massager, Nicolas |
author_facet | Lonneville, Sarah Delbrouck, Carine Renier, Cécile Devriendt, Daniel Massager, Nicolas |
author_sort | Lonneville, Sarah |
collection | PubMed |
description | BACKGROUND: Gamma Knife (GK) surgery is a recognized treatment option for the management of small to medium-sized vestibular schwannoma (VS) associated with high-tumor control and low morbidity. When a radiosurgical treatment fails to stop tumor growth, repeat GK surgery can be proposed in selected cases. METHODS: A series of 27 GK retreatments was performed in 25 patients with VS; 2 patients underwent three procedures. The median time interval between GK treatments was 45 months. The median margin dose used for the first, second, and third GK treatments was 12 Gy, 12 Gy, and 14 Gy, respectively. Six patients (4 patients for the second irradiation and 2 patients for the third irradiation) with partial tumor regrowth were treated only on the growing part of the tumor using a median margin dose of 13 Gy. The median tumor volume was 0.9, 2.3, and 0.7 cc for the first, second, and third treatments, respectively. Stereotactic positron emission tomography (PET) guidance was used for dose planning in 6 cases. RESULTS: Mean follow-up duration was 46 months (range 24–110). At the last follow-up, 85% of schwannomas were controlled. The tumor volume decreased, remained unchanged, or increased after retreatment in 15, 8, and 4 cases, respectively. Four patients had PET during follow-up, and all showed a significant metabolic decrease of the tumor. Hearing was not preserved after retreatment in any patients. New facial or trigeminal palsy did not occur after retreatment. CONCLUSIONS: Our results support the long-term efficacy and low morbidity of repeat GK treatment for selected patients with tumor growth after initial treatment. |
format | Online Article Text |
id | pubmed-4596053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45960532015-10-23 Repeat Gamma Knife surgery for vestibular schwannomas Lonneville, Sarah Delbrouck, Carine Renier, Cécile Devriendt, Daniel Massager, Nicolas Surg Neurol Int Original Article BACKGROUND: Gamma Knife (GK) surgery is a recognized treatment option for the management of small to medium-sized vestibular schwannoma (VS) associated with high-tumor control and low morbidity. When a radiosurgical treatment fails to stop tumor growth, repeat GK surgery can be proposed in selected cases. METHODS: A series of 27 GK retreatments was performed in 25 patients with VS; 2 patients underwent three procedures. The median time interval between GK treatments was 45 months. The median margin dose used for the first, second, and third GK treatments was 12 Gy, 12 Gy, and 14 Gy, respectively. Six patients (4 patients for the second irradiation and 2 patients for the third irradiation) with partial tumor regrowth were treated only on the growing part of the tumor using a median margin dose of 13 Gy. The median tumor volume was 0.9, 2.3, and 0.7 cc for the first, second, and third treatments, respectively. Stereotactic positron emission tomography (PET) guidance was used for dose planning in 6 cases. RESULTS: Mean follow-up duration was 46 months (range 24–110). At the last follow-up, 85% of schwannomas were controlled. The tumor volume decreased, remained unchanged, or increased after retreatment in 15, 8, and 4 cases, respectively. Four patients had PET during follow-up, and all showed a significant metabolic decrease of the tumor. Hearing was not preserved after retreatment in any patients. New facial or trigeminal palsy did not occur after retreatment. CONCLUSIONS: Our results support the long-term efficacy and low morbidity of repeat GK treatment for selected patients with tumor growth after initial treatment. Medknow Publications & Media Pvt Ltd 2015-09-28 /pmc/articles/PMC4596053/ /pubmed/26500799 http://dx.doi.org/10.4103/2152-7806.166173 Text en Copyright: © 2015 Surgical Neurology International http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Lonneville, Sarah Delbrouck, Carine Renier, Cécile Devriendt, Daniel Massager, Nicolas Repeat Gamma Knife surgery for vestibular schwannomas |
title | Repeat Gamma Knife surgery for vestibular schwannomas |
title_full | Repeat Gamma Knife surgery for vestibular schwannomas |
title_fullStr | Repeat Gamma Knife surgery for vestibular schwannomas |
title_full_unstemmed | Repeat Gamma Knife surgery for vestibular schwannomas |
title_short | Repeat Gamma Knife surgery for vestibular schwannomas |
title_sort | repeat gamma knife surgery for vestibular schwannomas |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596053/ https://www.ncbi.nlm.nih.gov/pubmed/26500799 http://dx.doi.org/10.4103/2152-7806.166173 |
work_keys_str_mv | AT lonnevillesarah repeatgammaknifesurgeryforvestibularschwannomas AT delbrouckcarine repeatgammaknifesurgeryforvestibularschwannomas AT reniercecile repeatgammaknifesurgeryforvestibularschwannomas AT devriendtdaniel repeatgammaknifesurgeryforvestibularschwannomas AT massagernicolas repeatgammaknifesurgeryforvestibularschwannomas |